Windtree Therapeutics Inc... (WINT)
NASDAQ: WINT
· Real-Time Price · USD
0.51
-0.01 (-1.28%)
At close: Aug 15, 2025, 3:57 PM
0.51
-1.07%
After-hours: Aug 15, 2025, 07:58 PM EDT
Windtree Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 22K | 14K | 120K | n/a | 135K | 131K | 155K | 640K | 224K | 216K | 214K | 215K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -22K | -14K | -120K | n/a | -135K | -131K | -155K | -640K | -224K | -216K | -214K | -215K |
Operating Income | -4.09M | -5.54M | -4.74M | -11.45M | -4.41M | -4.96M | -4.69M | -6.76M | -4.19M | -10.81M | -4.65M | -17.54M | -8.33M | -14.69M | -8.15M | -45.36M | -9.08M |
Interest Income | 7K | 8K | 12K | 20K | 30K | 61K | 112K | 108K | 44K | 52K | 39K | 17K | 1K | 1K | 1K | 39K | 50K |
Pretax Income | -4.04M | 2.69M | -2.99M | -11.83M | 10.33M | -5.15M | -4.42M | -6.6M | -4.11M | -11.06M | -4.06M | -17.33M | -8.13M | -14.73M | -8.21M | -45.72M | -8.96M |
Net Income | -4.04M | 2.77M | -2.75M | -12.02M | 10.22M | -5.15M | -4.42M | -6.6M | -4.11M | -9.69M | -3.46M | -17.13M | -7.92M | -13.07M | -8.21M | -37.39M | -8.96M |
Selling & General & Admin | 1.82M | 2.23M | 2.77M | 1.59M | 2.15M | 1.91M | 2.58M | 2.42M | 2.29M | 2.24M | 2.65M | 2.91M | 2.99M | 2.97M | 3.47M | 3.37M | 4.67M |
Research & Development | 2.27M | 2.19M | 1.97M | 9.86M | 2.23M | 3.03M | 2.11M | 1.76M | 1.42M | 1.22M | 1.54M | 3M | 5.34M | 4.48M | 4.68M | 4.22M | 4.41M |
Other Expenses | n/a | 1.12M | n/a | n/a | n/a | n/a | n/a | -39K | 484K | -286K | 569K | 201K | 218K | -24K | -53K | -352K | 109K |
Operating Expenses | 4.09M | 5.54M | 4.74M | 11.45M | 4.41M | 4.94M | 4.69M | 4.18M | 4.19M | 3.46M | 4.2M | 5.9M | 8.33M | 7.44M | 8.15M | 7.59M | 9.08M |
Interest Expense | 20K | 61K | 51K | 110K | 13K | 12K | 13K | 13K | 12K | 13K | 14K | 13K | 13K | 13K | 14K | 46K | 41K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.09M | 5.54M | 4.74M | 11.45M | 4.41M | 4.96M | 4.69M | 4.18M | 4.19M | 3.46M | 4.2M | 5.9M | 8.33M | 7.44M | 8.15M | 7.59M | 9.08M |
Income Tax Expense | n/a | -77K | -240K | 197K | 114K | n/a | n/a | n/a | n/a | -1.37M | -594K | -205K | -206K | -1.66M | -39K | -8.33M | n/a |
Shares Outstanding (Basic) | 10.88K | 256.4K | 17.74K | 11.5K | 9.3K | 6.66K | 5.72K | 4.48K | 958.89 | 858.00 | 691.89 | 648.89 | 628.78 | 626.67 | 593.42 | 585.56 | 393.22 |
Shares Outstanding (Diluted) | 10.88K | 256.4K | 17.74K | 11.5K | 9.3K | 6.66K | 5.72K | 4.48K | 958.89 | 858.00 | 691.89 | 648.89 | 628.78 | 626.67 | 593.42 | 585.56 | 393.22 |
EPS (Basic) | -4.63 | 0.27 | -211.39 | -1.05K | 1.1K | -773.54 | -773.6 | -1.47K | -4.29K | -11.29K | -5.86K | -26.71K | -12.92K | -20.86K | -13.84K | -63.85K | -22.79K |
EPS (Diluted) | -4.63 | 0.27 | -211.39 | -1.05K | 1.1K | -773.54 | -773.6 | -1.47K | -4.29K | -11.29K | -5.86K | -26.71K | -12.92K | -20.86K | -13.84K | -63.85K | -22.79K |
EBITDA | -4.01M | 2.75M | -2.81M | -11.49M | 10.37M | -5.12M | -4.4M | -6.47M | -4.08M | -10.91M | -3.91M | -17.16M | -7.47M | -14.49M | -7.98M | -45.46M | -8.71M |
EBIT | -4.03M | 2.75M | -2.94M | -11.72M | 10.35M | -5.14M | -4.41M | -6.59M | -4.1M | -11.05M | -4.04M | -17.32M | -8.11M | -14.71M | -8.2M | -45.67M | -8.92M |
Depreciation & Amortization | 17K | -293K | 127K | 229K | 21K | 22K | 14K | 120K | 23K | 135K | 131K | 155K | 640K | 224K | 216K | 214K | 215K |